Evolution in the management of chronic lymphocytic leukemia in Japan: should MRD negativity be the goal?
Saved in:
| Title: | Evolution in the management of chronic lymphocytic leukemia in Japan: should MRD negativity be the goal? |
|---|---|
| Authors: | Suzumiya J; Innovative Cancer Center/Oncology-Hematology, Shimane University Hospital, 89-1 Enya, Izumo, Shimane, 693-8501, Japan. suzumiya@med.shimane-u.ac.jp.; Department of Hematology, Koga community hospital, 2-30-1 Daikakuji, Yaizu, Shizuoka, 425-0088, Japan. suzumiya@med.shimane-u.ac.jp., Takizawa J; Department of Hematology, Endocrinology and Metabolism, Niigata University, Faculty of Medicine, Niigata, Japan. |
| Source: | International journal of hematology [Int J Hematol] 2020 May; Vol. 111 (5), pp. 642-656. Date of Electronic Publication: 2020 Apr 06. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Springer Japan Country of Publication: Japan NLM ID: 9111627 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1865-3774 (Electronic) Linking ISSN: 09255710 NLM ISO Abbreviation: Int J Hematol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
